Kenneth Moore, MD
Orthopaedic Surgery · Birmingham, ALNPI 1184646473
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $313,375 of the $341,501 with a category attached, or 91.8%. Stryker accounts for 99.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $130,737 and has fallen 92.5% since, to $9,823 in 2025. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $1566.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$341K
- Innovation Technologies Inc$168
- Osteoremedies, LLC$166
- Orthalign Inc$147
- Sanara Medtech Inc.$146
- Biocomposites Inc$121
- plus $227 from 9 others
What the payments were for
- Consulting fees$313,37592%
- Travel & lodging$24,9067%
- Food & beverage$3,2201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 204 | $340,525 |
| Innovation Technologies Inc | 1 | $168 |
| Osteoremedies, LLC | 1 | $166 |
| Orthalign Inc | 1 | $147 |
| Sanara Medtech Inc. | 1 | $146 |
| Biocomposites Inc | 1 | $121 |
| Illuminoss Medical, Inc. | 1 | $64 |
| Convatec Inc. | 1 | $26 |
| Conmed Corporation | 1 | $23 |
| Molnlycke Health Care US, LLC | 1 | $23 |
| Vertex | 1 | $20 |
| AbbVie | 1 | $20 |
| BD | 1 | $20 |
| Amgen | 1 | $16 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$337,241
- NEW PRODUCT DEVELOPMENT$889
- Irrisept$168
- BlastX$166
- Xperience$166
- ORTHALIGN PLUS$147
- CellerateRx$146
- Stimulan$121
How this compares
$341,501 in reported general payments places this provider in the 95th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 470 | $4,118 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 46 | $522 |
| Ondansetron OdtOndansetron | 21 | $204 |
| Meloxicam | 56 | $159 |
| Cephalexin | 65 | $101 |
| Tramadol Hcl | 31 | $80 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Birmingham
- Jeffrey DugasBirmingham$11.5M
- Benton EmblomBirmingham$3M
- Herrick SiegelBirmingham$1.2M
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$217K
- Ginger BryantBirmingham$209K
- Marcus RothermichBirmingham$207K
- Daniel KimBirmingham$147K
- Eugene BrabstonBirmingham$117K
- Michael JohnsonBirmingham$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.